Redefining Available Therapy in Oncology Accelerated Approval Decisions

S Shruti Rajesh Patel (Stanford University, Palo Alto, CA) M Maya Ramachandran (Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA) A Angela Ai (Department of Internal Medicine, UCLA-Olive View, Sylmar, CA) C Christopher T. Chen

Abstract

When weighing rapid approval for follow-on drugs, should @FDAOncology recognize the drugs that came before?

Article Details

Volume / Issue Vol. 43, Issue 6
Published February 20, 2025
Pages 629-632
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (4)

S

Shruti Rajesh Patel

Stanford University, Palo Alto, CA

M

Maya Ramachandran

Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA

A

Angela Ai

Department of Internal Medicine, UCLA-Olive View, Sylmar, CA

C

Christopher T. Chen